The European Drug Report 2023: Trends and Developments
The European Drug report 2023: Trends and Developments is the latest annual report on drug situation in Europe published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The report is centred on the topics of illegal drug consumption, associated risks, and drug distribution. Its objective is to provide a concise overview of the current drug landscape in Europe, based on an extensive collection of national data, encompassing developments and trends up to the end of 2022.
This year's report has been designed as a digital-first publication for the first time. It is interactive and visually rich, with over 100 data visualisations, graphics and maps. Additionally, all of the source data behind the visualisations was made available for sharing and reuse on the day of publication of the report.
It is particularly important as open data can provide a more comprehensive understanding of the current drug situation in Europe in relation to a number of aspects. Since 2011, the EMCDDA has been conducting studies on wastewater analysis and drug trends across Europe by combining open data from scientific studies into an interactive map. In the 2023 report, EMCDDA has also assessed the various drug harm reduction efforts undertaken by European countries.
These initiatives align with a broader European trend of using open data to improve public health. If you are interested to find out more, read the European Drug Report 2023, check the data behind its visualisations and find other relevant datasets providing insights into the trends related to drugs in Europe.